Skip to main content

Voio, a startup launched by a computer scientist from the University of California, Berkeley, is developing AI technology to assist radiologists in interpreting medical images more quickly and accurately. Their goal is to support healthcare professionals by detecting hundreds of medical conditions through advanced image analysis, improving both speed and precision in diagnostics.

Berkeley-Spun AI Startup Aims to Accelerate and Enhance Radiology with Advanced Image Analysis

In an episode of "The Readout LOUD," STAT reporters sit down with Mark Cuban to explore his thoughts on the growing direct-to-consumer trend in healthcare and why he supports TrumpRx as a positive development.

Mark Cuban Shares Bold Vision for Healthcare Revolution

A pioneering initiative at Harvard educates future doctors about the inherent structural problems within the healthcare system, aiming to foster deeper understanding and improved care strategies.

Harvard Program Illuminates Structural Issues in Healthcare for Medical Students

All physicians should acquire a basic understanding of artificial intelligence, highlighting the need for a potential licensing exam to ensure competency.

The Imperative for Physicians to Achieve Fundamental AI Literacy

Merck has announced plans to acquire Cidara Therapeutics, the developer of a promising experimental flu treatment, in a deal valued at $9.2 billion.

Merck to Acquire Cidara Therapeutics in $9.2 Billion Deal

Marty Makary and Vinay Prasad of the FDA have proposed a streamlined framework for developing CRISPR gene-editing treatments on demand. This approach promises faster delivery of personalized medicines, potentially transforming care for families in need of urgent genetic therapies. Experts weigh in on the innovation's impact and future possibilities in gene-editing medicine development.

Expert Perspectives on Streamlining CRISPR Gene-Editing Therapies

In the latest edition of STAT's Health Tech newsletter, Pfizer reveals its developing initiatives in digital health technology, highlighting the company's growing commitment to innovation in healthcare. This update includes insights into Pfizer's strategic direction and other relevant health tech industry news.

Pfizer's Emerging Focus on Digital Health Innovations

AbbVie is concluding its ten-year collaboration with Calico Life Sciences, a biotech firm funded by Alphabet that specializes in aging research. Alongside this, AbbVie has announced layoffs affecting its scientific workforce.

AbbVie Ends Partnership with Google-Backed Calico Life Sciences, Lays Off Research Staff

This week's AI Prognosis newsletter covers insights on Microsoft's approach to 'humanist superintelligence,' updates on AI vendors working with Medicare, and other relevant news in the field of artificial intelligence.

AI Perspectives: Microsoft's Vision, Medicare's AI Vendors, and More

Medicare has announced it will pay more than $1,000 for artificial intelligence to analyze heart scans, sparking debate over whether this cost is too high.

Medicare Allocates Over $1,000 for AI-Based Heart Scan Analysis: Is It Justified?